Sponsored By

Conflicting Messages on Drug-Eluting Stents

A Swedish study, based on a patient registry, found that clotting issues related to drug-eluting stents are not as frequent as previously thought. A respite for Boston Scientific and Johnson & Johnson, right? Not so fast.

September 5, 2007

1 Min Read
Conflicting Messages on Drug-Eluting Stents

Yesterday another registry-based study was made public which found that drug-eluting stents are linked to higher death rates for patients who have suffered a certain kind of heart attack, reports Bloomberg News.While better than consistently bad results, conflicting results don't help a device's prospects, as doctors and patients may turn cautious about its use, whether because of conservatism or confusion. J&J issued a statement saying the new study's results should not be heeded because they are out of line with other study results. But that message may not get through, given the noise that's been introduced into the debate.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like